Orange Book product · Brand (NDA)
VAZALORE
ASPIRIN
At a glance
Jan 14, 2013
Approved
Brand (NDA)
Application
Not listed
TE code
6
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 14, 2013
13 yr 7 mo ago
Today
Patent 10646431 expires
Listed drug product patent expiration.
Sep 29, 2032
in 6 yr 4 mo
Patent 10786444 expires
Listed method-of-use patent (U-3559) expiration.
Sep 29, 2032
in 6 yr 4 mo
Patent 9216150 expires
Listed drug product patent expiration.
Sep 29, 2032
in 6 yr 4 mo
Patent 9226892 expires
Listed method-of-use patent (U-1733) expiration.
Sep 29, 2032
in 6 yr 4 mo
Patent 9226892 expires
Listed method-of-use patent (U-1731) expiration.
Sep 29, 2032
in 6 yr 4 mo
Patent 9226892 expires
Listed method-of-use patent (U-1732) expiration.
Sep 29, 2032
in 6 yr 4 mo
Pharmaceutical detail
Active ingredient
ASPIRIN
Strength
325MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 203697
Product number
001
Marketing status
OTC
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (6)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10646431 | Sep 29, 2032 | in 6 yr 4 mo | Product |
| 10786444 | Sep 29, 2032 | in 6 yr 4 mo | U-3559 |
| 9216150 | Sep 29, 2032 | in 6 yr 4 mo | Product |
| 9226892 | Sep 29, 2032 | in 6 yr 4 mo | U-1733 |
| 9226892 | Sep 29, 2032 | in 6 yr 4 mo | U-1731 |
| 9226892 | Sep 29, 2032 | in 6 yr 4 mo | U-1732 |
